389 related articles for article (PubMed ID: 29660014)
1. IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors.
Müller S; Bley N; Glaß M; Busch B; Rousseau V; Misiak D; Fuchs T; Lederer M; Hüttelmaier S
Nucleic Acids Res; 2018 Jul; 46(12):6285-6303. PubMed ID: 29660014
[TBL] [Abstract][Full Text] [Related]
2. The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family.
Busch B; Bley N; Müller S; Glaß M; Misiak D; Lederer M; Vetter M; Strauß HG; Thomssen C; Hüttelmaier S
Nucleic Acids Res; 2016 May; 44(8):3845-64. PubMed ID: 26917013
[TBL] [Abstract][Full Text] [Related]
3. IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner.
Müller S; Glaß M; Singh AK; Haase J; Bley N; Fuchs T; Lederer M; Dahl A; Huang H; Chen J; Posern G; Hüttelmaier S
Nucleic Acids Res; 2019 Jan; 47(1):375-390. PubMed ID: 30371874
[TBL] [Abstract][Full Text] [Related]
4. The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer.
Müller S; Bley N; Busch B; Glaß M; Lederer M; Misiak C; Fuchs T; Wedler A; Haase J; Bertoldo JB; Michl P; Hüttelmaier S
Nucleic Acids Res; 2020 Sep; 48(15):8576-8590. PubMed ID: 32761127
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
Bell JL; Wächter K; Mühleck B; Pazaitis N; Köhn M; Lederer M; Hüttelmaier S
Cell Mol Life Sci; 2013 Aug; 70(15):2657-75. PubMed ID: 23069990
[TBL] [Abstract][Full Text] [Related]
6. IGF2BP1: a post-transcriptional "driver" of tumor cell migration.
Stöhr N; Hüttelmaier S
Cell Adh Migr; 2012; 6(4):312-8. PubMed ID: 22983196
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor 2 mRNA-binding protein 1 promotes cell proliferation
Wan BS; Cheng M; Zhang L
World J Gastroenterol; 2019 Oct; 25(40):6063-6076. PubMed ID: 31686763
[TBL] [Abstract][Full Text] [Related]
8. ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia.
Stoskus M; Vaitkeviciene G; Eidukaite A; Griskevicius L
Blood Cells Mol Dis; 2016 Mar; 57():30-4. PubMed ID: 26852652
[TBL] [Abstract][Full Text] [Related]
9. IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer.
Glaß M; Misiak D; Bley N; Müller S; Hagemann S; Busch B; Rausch A; Hüttelmaier S
Front Mol Biosci; 2021; 8():632219. PubMed ID: 33829040
[TBL] [Abstract][Full Text] [Related]
10. The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer.
Lederer M; Bley N; Schleifer C; Hüttelmaier S
Semin Cancer Biol; 2014 Dec; 29():3-12. PubMed ID: 25068994
[TBL] [Abstract][Full Text] [Related]
11. IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer.
Bley N; Schott A; Müller S; Misiak D; Lederer M; Fuchs T; Aßmann C; Glaß M; Ihling C; Sinz A; Pazaitis N; Wickenhauser C; Vetter M; Ungurs O; Strauss HG; Thomssen C; Hüttelmaier S
RNA Biol; 2021 Mar; 18(3):391-403. PubMed ID: 32876513
[TBL] [Abstract][Full Text] [Related]
12. miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1.
Rebucci M; Sermeus A; Leonard E; Delaive E; Dieu M; Fransolet M; Arnould T; Michiels C
Mol Cancer; 2015 Apr; 14():79. PubMed ID: 25889892
[TBL] [Abstract][Full Text] [Related]
13. miR-1275: A single microRNA that targets the three IGF2-mRNA-binding proteins hindering tumor growth in hepatocellular carcinoma.
Fawzy IO; Hamza MT; Hosny KA; Esmat G; El Tayebi HM; Abdelaziz AI
FEBS Lett; 2015 Aug; 589(17):2257-65. PubMed ID: 26160756
[TBL] [Abstract][Full Text] [Related]
14. IMP3 RNP safe houses prevent miRNA-directed HMGA2 mRNA decay in cancer and development.
Jønson L; Christiansen J; Hansen TVO; Vikeså J; Yamamoto Y; Nielsen FC
Cell Rep; 2014 Apr; 7(2):539-551. PubMed ID: 24703842
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells.
Ohdaira H; Sekiguchi M; Miyata K; Yoshida K
Cell Prolif; 2012 Feb; 45(1):32-8. PubMed ID: 22151897
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis.
Su Y; Xiong J; Hu J; Wei X; Zhang X; Rao L
Oncotarget; 2016 Oct; 7(42):68397-68411. PubMed ID: 27588393
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicle-dependent effect of RNA-binding protein IGF2BP1 on melanoma metastasis.
Ghoshal A; Rodrigues LC; Gowda CP; Elcheva IA; Liu Z; Abraham T; Spiegelman VS
Oncogene; 2019 May; 38(21):4182-4196. PubMed ID: 30936459
[TBL] [Abstract][Full Text] [Related]
18. Restoration of microRNA-708 sensitizes ovarian cancer cells to cisplatin via IGF2BP1/Akt pathway.
Qin X; Sun L; Wang J
Cell Biol Int; 2017 Oct; 41(10):1110-1118. PubMed ID: 28685895
[TBL] [Abstract][Full Text] [Related]
19. IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression.
Zhang L; Wan Y; Zhang Z; Jiang Y; Gu Z; Ma X; Nie S; Yang J; Lang J; Cheng W; Zhu L
Theranostics; 2021; 11(3):1100-1114. PubMed ID: 33391523
[No Abstract] [Full Text] [Related]
20. IGF2BP1 harbors prognostic significance by gene gain and diverse expression in neuroblastoma.
Bell JL; Turlapati R; Liu T; Schulte JH; Hüttelmaier S
J Clin Oncol; 2015 Apr; 33(11):1285-93. PubMed ID: 25753434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
